Biologics Discovery and Development

Exponential power to transform drug discovery.

One ecosystem. Three forces: AI, Data, Advanced Lab Research.

A fundamental shift in biologics discovery

By uniting AI, data, and advanced lab research into an integrated ecosystem, we support deeper biological insight and connected evidence—enabling diversity, scale, and specificity as programs move forward. Your success is our success.

Drug Discover shift in biologics, construction of a square tower

Research highlights & innovation news

Argenx read the article Genmab read news Janssen Pharma read the news NIH read the news Novo Nordisk read the article Onco Response read the news MJ Fox Foundation see filing

A comprehensive biontelligence ecosystem

Discovery no longer follows a single linear path. Advantage now comes from adaptability and a high-throughput ecosystem that connects every facet of R&D. As AI makes discovery more fluid, researchers can surround their targets in new ways to explore biological evidence, refine hypotheses, and advance promising candidates with greater precision and efficiency.

Customized biologics discovery R&D path

The biologics path is wide—spanning therapeutic, anti-drug and diagnostic antibodies, peptide-based therapies, vaccines and beyond. It’s a path that demands versatility, scale, and the power to adapt with every program.

Customized technologies

Transformation starts here, tackling complex challenges across the industry and within your program. More than tools. More than technology. AI, data, and lab capabilities working together in a flexible combination designed to fit your needs.

952
Therapeutic Antibodies +
Anti-Drug Antibodies +
Diagnostic Antibodies +
Peptide Therapeutics
Vaccine Discovery
Bio-native AI +
Data Integration +
Advanced Lab Research +

Customized biologics discovery R&D path

The biologics path is wide—spanning therapeutic, anti-drug and diagnostic antibodies, peptide-based therapies, vaccines and beyond. It’s a path that demands versatility, scale, and the power to adapt with every program.

Therapeutic Antibodies +

Therapeutic Antibodies

Transformative workflows driving discovery success.

Anti-Drug Antibodies +

Anti-Drug Antibodies

High success. High reliability. High client retention.

Diagnostic Antibodies +

Diagnostic Antibodies

Performance and scale for precision detection.

Peptide Therapeutics

Peptide Therapeutics

Unlocking new opportunities through peptide discovery.

Vaccine Discovery

Vaccine Discovery

Power to uncover rare insights for faster discovery.

952

Customized technologies

Transformation starts here, tackling complex challenges across the industry and within your program. More than tools. More than technology. AI, data, and lab capabilities working together in a flexible combination designed to fit your needs.

Bio-native AI +

Bio-native AI

Biological reasoning at scale to explore, refine, generate and accelerate.

Data Integration +

Data Integration

Unified insights across sequence, structure, and function.

Advanced Lab Research +

Advanced Lab Research

Demonstrated success driving diverse discovery breakthroughs.

Designed with the market in mind.
Built for challenges.

Committed to redefining what’s possible in biologics discovery.

Science. Technology. Rigor.

Expertise matters

Deep expertise in science and technology, applied strategically to guide programs and product development in support of discovery success.

3X
faster

Speed matters

Up to 3X faster from data to discovery.

Early stage
de-risking

Safety matters

Early-stage de-risking. AI and lab research converge to identify potential risks, refine candidates, and support stronger downstream outcomes.

>98%
success rate

Success matters

Greater than 98% discovery success* with leading B cell technology, supporting 15+ molecules advanced to the clinic.

* “Success” refers to meeting predefined discovery criteria, not clinical or therapeutic outcomes. Results may vary.

Take the first step

Let’s expand what’s possible for human health.

Case Studies

See validated insights that redefine workflows and advance discovery

Scientific Posters

Discover how MindWalk powers smarter paths from concept to clinic.

Blogs

Explore the latest ideas reshaping the future of discovery.

Spotlight

CaseXCase™: LensAI case study series

A collection of the latest results highlighting how new approaches are shaping modern discovery.

Drug Discovery Spotlight

Four ways to access MindWalk

We build it

Customizable offerings in biologics discovery—from target analysis to optimized leads.

You build it

Access to state-of-the-art LensAI SaaS platform.

The Vault

Smarter starts: a portfolio of partner-ready assets.

Partnership

We are proud to partner with the best in pharma, biotech and academia organizations. Join us in creating future of human health.